Landos Biopharma Inc (LABP)
22.93
+0.13
(+0.58%)
USD |
NASDAQ |
May 23, 16:00
22.93
0.00 (0.00%)
After-Hours: 20:00
Landos Biopharma Accounts Payable (Quarterly): 1.565M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.565M |
| December 31, 2023 | 1.375M |
| September 30, 2023 | 1.135M |
| June 30, 2023 | 1.029M |
| March 31, 2023 | 2.298M |
| December 31, 2022 | 3.435M |
| September 30, 2022 | 3.204M |
| June 30, 2022 | 4.711M |
| Date | Value |
|---|---|
| March 31, 2022 | 9.803M |
| December 31, 2021 | 12.91M |
| September 30, 2021 | 10.11M |
| June 30, 2021 | 10.68M |
| March 31, 2021 | 8.20M |
| December 31, 2020 | 8.606M |
| September 30, 2020 | 6.652M |
| December 31, 2019 | 2.048M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.029M
Minimum
Jun 2023
12.91M
Maximum
Dec 2021
5.486M
Average
4.073M
Median
Accounts Payable (Quarterly) Benchmarks
| AbbVie Inc | -- |
| Fusion Pharmaceuticals Inc | 2.503M |
| Masimo Corp | 203.10M |
| Kinnate Biopharma Inc (DELISTED) | 2.031M |
| Invivyd Inc | 1.168M |